Zenotech Laboratories Ltd (532039):企業の財務・戦略的SWOT分析

◆英語タイトル:Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81379FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Zenotech Laboratories Ltd (532039) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zenotech Laboratories Ltd (Zenotech Laboratories), a subsidiary of Sun Pharmaceutical Industries Ltd that manufactures and markets specialty pharmaceutical and biotechnology products. The company’s products include granulocyte-macrophage colony-stimulating factor (GMCSF) and granulocyte-colony stimulating factor (GCSF). It also offers contract manufacturing services for generic cancer, biopharmaceutical and generic anesthetic injectables. It has subsidiaries in Brazil and the US. Zenotech Laboratories is headquartered in Hyderabad, Telangana, India.

Zenotech Laboratories Ltd Key Recent Developments

Aug 14,2020: Zenotech Laboratories: cease of Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Zenotech Laboratories Ltd – Key Facts
Zenotech Laboratories Ltd – Key Employees
Zenotech Laboratories Ltd – Key Employee Biographies
Zenotech Laboratories Ltd – Major Products and Services
Zenotech Laboratories Ltd – History
Zenotech Laboratories Ltd – Company Statement
Zenotech Laboratories Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Zenotech Laboratories Ltd – Business Description
Zenotech Laboratories Ltd – Corporate Strategy
Zenotech Laboratories Ltd – SWOT Analysis
SWOT Analysis – Overview
Zenotech Laboratories Ltd – Strengths
Zenotech Laboratories Ltd – Weaknesses
Zenotech Laboratories Ltd – Opportunities
Zenotech Laboratories Ltd – Threats
Zenotech Laboratories Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Zenotech Laboratories Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 14, 2020: Zenotech Laboratories: cease of Chief Executive Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Zenotech Laboratories Ltd, Key Facts
Zenotech Laboratories Ltd, Key Employees
Zenotech Laboratories Ltd, Key Employee Biographies
Zenotech Laboratories Ltd, Major Products and Services
Zenotech Laboratories Ltd, History
Zenotech Laboratories Ltd, Subsidiaries
Zenotech Laboratories Ltd, Key Competitors
Zenotech Laboratories Ltd, Ratios based on current share price
Zenotech Laboratories Ltd, Annual Ratios
Zenotech Laboratories Ltd, Annual Ratios (Cont...1)
Zenotech Laboratories Ltd, Interim Ratios
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Zenotech Laboratories Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Zenotech Laboratories Ltd (532039):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Dusit Thani Public Company Limited:企業の戦略・SWOT・財務情報
    Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • OJSC Surgutneftegas:企業の戦略・SWOT・財務分析
    OJSC Surgutneftegas - Strategy, SWOT and Corporate Finance Report Summary OJSC Surgutneftegas - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Inoviem Scientific SAS-製薬・医療分野:企業M&A・提携分析
    Summary Inoviem Scientific SAS (Inoviem) is a contract research biotechnology company that offers preclinical and clinical services. The company develops solutions in the field of drug target interaction analysis and drug development. Its technologies include physiological intermolecular modulation …
  • Keppel Corporation Limited:企業の戦略・SWOT・財務分析
    Keppel Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Keppel Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • NxStage Medical Inc:企業の戦略的SWOT分析
    NxStage Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Surface Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Surface Oncology Inc (Surface Oncology) is a biopharmaceutical company that develops novel cancer immunotherapies for the treatment of cancer. The company develops treatments in which the immune system can be harnessed to fight cancer. It conducts pre-clinical study through new approaches to …
  • Sky plc:企業の戦略・SWOT・財務情報
    Sky plc - Strategy, SWOT and Corporate Finance Report Summary Sky plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Williams-Sonoma, Inc.:戦略・SWOT・企業財務分析
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Par Pacific Holdings, Inc. (PARR):企業の財務・戦略的SWOT分析
    Par Pacific Holdings, Inc. (PARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Nippon Paper Industries Co., Ltd.:戦略・SWOT・企業財務分析
    Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Albertsons Companies, Inc.:戦略・SWOT・企業財務分析
    Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ultra Electronics Holdings Plc:企業の戦略・SWOT・財務情報
    Ultra Electronics Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ultra Electronics Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Opthea Ltd (OPT):企業の財務・戦略的SWOT分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • Jupiter Energy Ltd (JPR):石油・ガス:M&Aディール及び事業提携情報
    Summary Jupiter Energy Ltd (Jupiter Energy) is an oil exploration and production company that carries out acquisition, exploration, production, and develops oil and natural gas properties. The company holds an exploration permit in the oil-rich Mangistau Basin in West Kazakhstan. It also holds inter …
  • MDC Holdings Inc:企業の戦略・SWOT・財務情報
    MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • JEA:企業の発電所・SWOT分析2018
    JEA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • BiosanaPharma BV:製薬・医療:M&Aディール及び事業提携情報
    Summary BiosanaPharma BV (Biosana) is a biotechnology company engaged in the development of monoclonal antibody biologicals (mAbs), biosimilars and biobetters. Its pipeline products include BP001: biosimilar of Omalizumab (anti-allergy); BP002: biosimilar of Denosumab (anti-osteoporosis); BOX001: or …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆